DUOX2 and colitis: DUOX2 in intestinal epithelial cells regulates host–microbiome interactions and homeostasis; its deletion alters the microbiome and reduces colitis susceptibility by limiting ROS-mediated damage, suggesting DUOX2 as a therapeutic target for intestinal inflammation [32].